dosReis, S., Bozzi, L.M., Butler, B., Xie, R.Z.Chapman, R.H., Bright, J., Malik, E., and Slejko,  J.F. “Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience.” The Patient – Patient-Centered Outcomes Research (2022).

Perfetto, E.M., Oehrlein, E.M., Love, T.R., Bright, J., and A. Kennedy. “Patient-Centered Core Impact Sets: What They Are and Why We Need Them.” The Patient – Patient-Centered Outcomes Research (2022).

Xie RZ, DosReis S, Kowal S, and Garrison L. “Addressing Health Equity in Value Assessments: A New Role for HEOR?” Value & Outcomes Spotlight. 2022;8(2):23-26.

Xie RZ, Bright JB, deFur Malik E, Chapman RH. “Early Reflections on Stakeholder Engagement in Economic Model Development to Inform Value Assessment.” Value & Outcomes Spotlight. 2022;8(2):37-40.

Van den Broek, R., Matheis, R., Bright, J. Hartog, T., and Perfetto, E. “Value-based Evidence Across Health Care Sectors: A Push for Transparent Real-World Studies, Data, and Evidence Dissemination.” Health Economics, Policy and Law. 2022.

Xie, R., Towse, A., and Garrison, L. “Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of ‘Failed’ R&D Efforts.” International Journal of Technology Assessment in Health Care. 2022;38(1), E31.

Xie RZ, Malik E deFur, Linthicum MT, Bright JL.Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States.” PharmacoEconomics. 2021;39(6):631-638.

Linthicum MT, dosReis S, Slejko JF, Mattingly TJ, Bright JL.The Importance of Collaboration in Pursuit of Patient-Centered Value Assessment.” The Patient. August 28, 2020:1-4.

Incerti D, Thom H, Baio G, Jansen JP. “R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.” Value in Health. 2019;22(5):575-579.

Jansen JP, Incerti D, Linthicum MT.Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.” PharmacoEconomics. 2019;37(11):1313-1320.

Incerti D, Curtis JR, Shafrin J, Lakdawalla DN, Jansen JP. “A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis.” PharmacoEconomics. 2019;37(6):829-843.

Jansen JP, Incerti D, Curtis JR. “Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System.” Journal of Managed Care & Specialty Pharmacy. 2019;25(5):518-521.

Reports

VIEW POSTER PRESENTATION

Resources